CY1115695T1 - NEW UNION USEFUL FOR TREATMENT OF DISEASES AND INFLAMMATORY DISEASES - Google Patents
NEW UNION USEFUL FOR TREATMENT OF DISEASES AND INFLAMMATORY DISEASESInfo
- Publication number
- CY1115695T1 CY1115695T1 CY20141100915T CY141100915T CY1115695T1 CY 1115695 T1 CY1115695 T1 CY 1115695T1 CY 20141100915 T CY20141100915 T CY 20141100915T CY 141100915 T CY141100915 T CY 141100915T CY 1115695 T1 CY1115695 T1 CY 1115695T1
- Authority
- CY
- Cyprus
- Prior art keywords
- diseases
- treatment
- compound
- new union
- useful
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Αποκαλύπτεται μια ένωση η οποία έχει τύπο που αντιπροσωπεύεται με τον παρακάτω: (I). Αυτή η ένωση μπορεί να παρασκευάζεται ως φαρμακευτική σύνθεση και μπορεί να χρησιμοποιηθεί για την πρόληψη και τη θεραπεία μιας ποικιλίας καταστάσεων σε θηλαστικά συμπεριλαμβανομένων ανθρώπων, που συμπεριλαμβάνουν ως μη περιοριστικό παράδειγμα, φλεγμονώδεις καταστάσεις, αυτοάνοσες ασθένειες, πολλαπλασιαστικές ασθένειες, απόρριψη μεταμόσχευσης, ασθένειες που περιλαμβάνουν εξασθένηση του ρυθμού ανανέωσης χόνδρου, συγγενείς δυσπλασίες χόνδρου ή/και ασθένειες που συνδυάζονται με υπερέκκριση IL6.A compound having a formula represented by the following is disclosed: (I). This compound can be prepared as a pharmaceutical composition and can be used to prevent and treat a variety of conditions in mammals including humans, including as a non-limiting example, inflammatory conditions, autoimmune diseases, proliferative diseases, transplant rejection, including disease cartilage renewal rate, congenital cartilage malformations and / or diseases associated with IL6 overexpression.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22068509A | 2009-06-26 | 2009-06-26 | |
| US29818810A | 2010-01-25 | 2010-01-25 | |
| EP10728648.6A EP2445912B1 (en) | 2009-06-26 | 2010-06-25 | Novel compound useful for the treatment of degenerative and inflammatory diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1115695T1 true CY1115695T1 (en) | 2017-01-25 |
Family
ID=58457000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20141100915T CY1115695T1 (en) | 2009-06-26 | 2014-11-04 | NEW UNION USEFUL FOR TREATMENT OF DISEASES AND INFLAMMATORY DISEASES |
Country Status (1)
| Country | Link |
|---|---|
| CY (1) | CY1115695T1 (en) |
-
2014
- 2014-11-04 CY CY20141100915T patent/CY1115695T1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1119711T1 (en) | NEW UNION USEFUL FOR TREATMENT OF DISEASES AND INFLAMMATORY DISEASES | |
| CY1119515T1 (en) | OXAZOL Substituted Indazoles as R3-Kinase Suspensions | |
| CY1118156T1 (en) | AMIDE REVERSE COMPOUNDS AS PROTEIN DETERMINATION INHIBITORS AND METHODS OF USING THESE | |
| CY1119214T1 (en) | 5-Finyl- [1,2,4] triazolo [1,5-A] pyridine-2-methyl carboxamide as JAK suspensions | |
| CY1119245T1 (en) | PHARMACEUTICAL COMPOSITION OF CARBETOKIN | |
| CY1123690T1 (en) | SPECIFICALLY FOR CD40L SCAFFOLDS DERIVED FROM TN3 AND METHODS OF USING THEREOF | |
| UA108743C2 (en) | HINAZOLINE-4 (3H) -ONE DERIVATIVES FOR APPLICATION AS RI-KINASE INHIBITORS | |
| IN2012DN03883A (en) | ||
| EA201270149A1 (en) | BACE INHIBITORS | |
| EA201100447A1 (en) | ORGANIC COMPOUNDS | |
| MA33939B1 (en) | 5-alkynyl-PYRIMIDINE | |
| MX2013012281A (en) | Novel compound useful for the treatment of degenerative and inflammatory diseases. | |
| ECSP11010831A (en) | ORGANIC COMPOUNDS FOR WOUND CICATRIZATION | |
| EA201200373A1 (en) | COMPOUNDS AND COMPOSITIONS AS PROTEINKINAZ INHIBITORS | |
| ATE517107T1 (en) | PYRROLOPYRAZINE KINASE INHIBITORS | |
| MY150542A (en) | Cmet inhibitors | |
| ATE522536T1 (en) | PYRROLOPYRAZINE KINASE INHIBITORS | |
| EA201590071A1 (en) | AMINOTRIAZOLOPIRIDINE FOR USE IN THE TREATMENT OF INFLAMMATION AND ITS PHARMACEUTICAL COMPOSITIONS | |
| MX2012002641A (en) | Inhibitors of jak. | |
| CL2009000503A1 (en) | Preparation process of compounds derived from 2-amino-5-cyanobenzoic acid-3-substituted or 1h-pyrazole-5-carboxamide. | |
| ATE522534T1 (en) | PYRROLOPYRAZINE KINASE INHIBITORS | |
| EA201400623A1 (en) | NEW 2H-INDASOLS AS ANTAGONISTS EP EPCEPTOR | |
| IN2012DN03846A (en) | ||
| MA32945B1 (en) | Tetrahydroperan spiro-pyrolidinone substituted biperidenone, its preparation and use in treatment | |
| UA107346C2 (en) | Use of nifuratel to treat infections caused by atopobium species |